Advertisement

Topics

BeFutur (Suisse) S.A. Company Profile

10:44 EDT 24th June 2018 | BioPortfolio

Considering the vast impact caused by the emergence of the biotechnologies, and eager to play a driving role in these evolutions, BeFutur Biotechnologies and its subsidiaries have set up an exclusive center in Europe, specialized in the culture of cells and tissues for therapeutic purposes. During the last 10 years, BeFutur has developed through own funding, its entire technology. This latter innovates on the market of biotechnologies while bringing a complete and safe response to the practice of the culture of cells and tissues for human clinical applications. To date the phase of research and development in the fields of cardiology, bio-cosmetic, aesthetic medicine and parodontology is finished, and BeFutur is fully operational, technically speaking, for the industrial phase and the marketing

Location

14, chemin des Clochettes
Geneva
1206
Switzerland

Contact

Phone: (41) 22 - 800 33 10
Fax: (41) 22 - 800 33 13
Email: info@befutur.com


News Articles [65 Associated News Articles listed on BioPortfolio]

Credit Suisse remains bullish on Ocado after recently attending European roadshow

Credit Suisse’s analysts pointed out that Ocado shares have fallen by more than 20% over the past 4 weeks, materially underperforming their food retailing peers

MICROSCOPE BINOCULAIRE ANCIEN ” KERN AARAU “. MADE IN SUISSE.

25,50 EUR (2 Enchères)Date de fin: jeudi avr.-5-2018 19:16:08 CESTEnchérir | Ajouter à vos Affaires à suivre Biotech365 : MICROSCOPE BINOCULAIRE ANCIEN ” KERN AARAU “. MADE IN SUI...

Credit Suisse belässt Gerresheimer auf 'Outperform'

Die Schweizer Bank Credit Suisse hat die Einstufung für Gerresheimer nach Zahlen zum ersten Geschäftsquartal auf "Outperform" mit einem Kursziel von 72 Euro belassen. Das Zahlenwerk des Verpackung.....

Shire (SHP) PT Lowered to GBX 4,000 at Credit Suisse Group

The firm presently has an "outperform" rating on the biopharmaceutical company's stock. Credit Suisse Group's price target would suggest a potential upside of 24.92% from the company's pre...

Credit Suisse senkt Ziel für Gerresheimer - 'Outperform'

Die Schweizer Bank Credit Suisse hat das Kursziel für Gerresheimer nach Zahlen von 75 auf 72 Euro gesenkt, aber die Einstufung auf "Outperform" belassen. Zwar sei das vierte Quartal überraschend g.....

Credit Suisse belässt Astrazeneca auf 'Outperform'

Die Schweizer Bank Credit Suisse hat die Einstufung für Astrazeneca auf "Outperform" mit einem Kursziel von 5800 Pence belassen. Nach einer Reihe an Patentabläufen befinde sich der Pharmaherstelle.....

Credit Suisse senkt Ziel für McDonalds - Bleibt 'Outperform'

Die Schweizer Bank Credit Suisse hat das Kursziel für McDonalds von 191 auf 175 US-Dollar gesenkt, aber die Einstufung auf "Outperform" belassen. Analyst Jason West senkte seine Wachstumsschätzung.....

Credit Suisse belässt Roche auf 'Underperform' - Ziel 215 Franken

Die Schweizer Bank Credit Suisse hat die Einstufung für Roche auf "Underperform" mit einem Kursziel von 215 Franken belassen. Die Markterwartungen für den Pharmakonzern erschienen viel zu hoch, sc.....

Drugs and Medications [2 Associated Drugs and Medications listed on BioPortfolio]

Cellular radiance spf 30 [La Prairie, Inc.]

Cellular Radiance Emulsion SPF 30

Asacol [Cardinal Health]

Asacol (mesalamine)Delayed-Release Tablets

Clinical Trials [0 Results]

None

Companies [4 Associated Companies listed on BioPortfolio]

BeFutur (Suisse) S.A.

Considering the vast impact caused by the emergence of the biotechnologies, and eager to play a driving role in these evolutions, BeFutur Biotechnologies and its subsidiaries have set up an exclusive ...

Gen Suisse

Nil

Credit Suisse

We were one of the first investment banks to create specialized global industry groups, each dedicated to providing unmatched industry knowledge to its clients. Each industry is covered by senior prof...

Renaissance Capital Milestones

Renaissance Capital, founded in 1991 and headquartered in Greenwich, CT, is the leading provider of independent research and investment management services focused on newly public companies. The Firm ...

More Information about "BeFutur (Suisse) S.A." on BioPortfolio

We have published hundreds of BeFutur (Suisse) S.A. news stories on BioPortfolio along with dozens of BeFutur (Suisse) S.A. Clinical Trials and PubMed Articles about BeFutur (Suisse) S.A. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BeFutur (Suisse) S.A. Companies in our database. You can also find out about relevant BeFutur (Suisse) S.A. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...


Corporate Database Quicklinks



Searches Linking to this Company Record